课题基金 / 基金详情

MECHANISMS OF SUSCEPTIBILITY TO ALLOXAN IN MICE

MECHANISMS OF SUSCEPTIBILITY TO ALLOXAN IN MICE
小鼠对四氧嘧啶的敏感性机制
批准号:
2708497
负责人:
CLAYTON E MATHEWS
金额:
$2.62万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
未结题
起止时间:
1999-02-05 至

项目摘要

项目成果

CLAYTON E MATHEWS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Free radicals are reactive oxygen species that are especially damaging to pancreatic Beta-cell They are generated within Beta-cell They are generated within Beta-cells by the combination of cytokines secreted by leukocytes comprising the insulitic infiltrate during development of insulin dependent diabetes (IDDM). Destructive oxygen free radicals are generated in Beta-cells after exposure to environmental toxins, such as alloxan (AL). Al, resembling the glucose molecule, is selectively taken up rodent Beta-cell wherein it decomposes to produce highly toxic oxygen free radicals. Beta-cells have weaker defenses to oxidative damage than do cells from other tissues. Unknown whether or not genes expressed in B-cells can contribute to the overall make-up of an individual is genetically susceptible or resistant to Beta-cell loss. The goal of this fellowship proposal is to address this question using two inbred strains of mice selected for alloxan susceptibility (ALS) versus (ALR) IDDM induction. The basis for this differential in alloxan susceptibility is apparently the ability of the ALR strain to ~defuse~ the alloxan-generated free radical stress. The same pattern of susceptibility/resistance holds for treatment with streptozotocin, another Beta cell toxin. Biochemical analyze will test whether the strains different in systemic and/or islet defenses to the reactive oxygen species generate AL. Genetic segregation analysis will elucidate the gene or genes controlling differential susceptibility. Finally, Islets in vitro will be tested for ability to resist free radical mediated stress induced by combinations of cytotoxic cytokines. The elucidation of the genetic basis for the heightened resistance to Beta cell toxins should have practical applications in therapies for IDDM, including islet transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
  • 批准号:
    10589578
  • 项目类别:
  • 资助金额:
    $71.57万
  • 财政年份:
    2023
  • 负责人:
    CLAYTON E MATHEWS
  • 依托单位:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
Organ Specific Project